Donor natural killer (NK) cell infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor natural killer (NK) cell infusion, covering 2012-07-16 to 2012-07-16. Get the full timeline:
Most recent: Clinical Trial Update: Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML [Phase 2]